Position in LLY
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$841,920,666
-$141,798,510 QoQ
Shares Held
915,360
0.0% QoQ
Ownership
0.097%
of shares outstanding
% of Portfolio
1.41%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2023CallValue
$0
CallShares
0
PutValue
$468,980
PutShares
1,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026DekaBank Deutsche Girozentrale holds $4,975,685,636 across 11 Drug Manufacturers - General names. LLY ranks #2 (16.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,411,321 | $1,078,303,305 | |
| 2 | LLY |
ELI LILLY & Co
This page
|
915,360 | $841,920,666 | |
| 3 | AZN |
Astrazeneca PLC
|
3,783,927 | $746,266,082 | |
| 4 | ABBV |
AbbVie Inc.
|
3,054,882 | $664,406,285 | |
| 5 | MRK |
Merck & Co., Inc.
|
5,427,912 | $652,923,533 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,040,494 | $284,383,648 | |
| 7 | AMGN |
Amgen Inc
|
711,647 | $250,392,996 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,782,490 | $229,408,018 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $841,920,666 | 915,360 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $983,719,176 | 915,360 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $698,419,680 | 915,360 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $713,550,579 | 915,360 | Shares | Defined | 2025-07-30 | |
| 2025-03-31 | $752,508,900 | 911,127 | Shares | Defined | 2025-04-30 | |
| 2024-12-31 | $706,657,920 | 915,360 | Shares | Defined | 2025-01-29 | |
| 2024-09-30 | $810,954,038 | 915,360 | Shares | Defined | 2024-10-24 | |
| 2024-06-30 | $830,441,697 | 917,230 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $708,820,360 | 911,127 | Shares | Defined | 2024-06-04 | |
| 2023-12-31 | $515,824,741 | 884,898 | Shares | Defined | 2024-01-24 | |
| 2023-09-30 | $478,986,214 | 891,751 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $468,980 | 1,000 | Put | Defined | 2023-07-25 | |
| 2023-06-30 | $357,647,899 | 762,608 | Shares | Defined | 2023-07-25 | |
| 2023-03-31 | $258,182,125 | 751,797 | Shares | Defined | 2023-04-24 | |
| 2022-12-31 | $263,888,805 | 721,323 | Shares | Defined | 2023-02-01 | |
| 2022-09-30 | $210,692,595 | 651,593 | Shares | Defined | 2022-11-02 | |
| 2022-06-30 | $204,948,051 | 632,107 | Shares | Defined | 2022-08-03 | |
| 2022-03-31 | $178,924,261 | 624,801 | Shares | Defined | 2022-04-28 | |
| 2021-12-31 | $185,697,733 | 672,282 | Shares | Defined | 2022-02-02 | |
| 2021-09-30 | $144,899,541 | 627,135 | Shares | Defined | 2021-10-22 | |
| 2021-06-30 | $127,855,721 | 557,057 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $122,995,375 | 658,363 | Shares | Defined | 2021-04-28 | |
| 2020-12-31 | $142,016,895 | 841,133 | Shares | Defined | 2021-03-12 | |
| 2020-09-30 | $88,832,869 | 600,141 | Shares | Defined | 2020-10-29 | |
| 2020-06-30 | $49,330,836 | 300,468 | Shares | Defined | 2020-08-04 | |
| 2020-03-31 | $41,421,375 | 298,597 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||